Related Experiment Videos
Methodological issues in AIDS clinical trials. Discussion. Design of clinical trials--active control (equivalence)
D Richman1, L Itri, M F Johnson
1Department of Pathology and Medicine, University of California, San Diego.
Journal of Acquired Immune Deficiency Syndromes
|January 1, 1990
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Enhanced production of 60Fe in massive stars.
Nature communications·2024
β Decay of ^{61}V and its Role in Cooling Accreted Neutron Star Crusts.
Physical review letters·2021
Clinical Features and Disease Management in Adult Patients With Atopic Dermatitis Receiving Care at Reference Hospitals in Brazil: the ADAPT Study.
Journal of investigational allergology & clinical immunology·2020
Nocturnal river water temperatures: Spatial and temporal variations.
The Science of the total environment·2014
Detection of HIV-1 in alternative specimen types using the APTIMA HIV-1 RNA Qualitative Assay.
Journal of virological methods·2009
Seroprevalence of HIV-1 and syphilis antibodies in blood donors in Gonder, Ethiopia, 1989-1993.
Journal of acquired immune deficiency syndromes·1994
Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986-1992.
Journal of acquired immune deficiency syndromes·1994
Incidence of HIV-1 infection among young men in Thailand.
Journal of acquired immune deficiency syndromes·1994
Resistance to HIV-1 infection. Multicenter AIDS Cohort Study.
Journal of acquired immune deficiency syndromes·1994
Health care delivery, zidovudine use, and survival of women and men with AIDS.
Journal of acquired immune deficiency syndromes·1994
Thrush and fever as measures of immunocompetence in HIV-1-infected men.
Journal of acquired immune deficiency syndromes·1994
Overexpression of TCF7L2 promotes the viability and migration of MHCC-97H human hepatocellular carcinoma cells by upregulating MT-ND4L.
Translational cancer research·2026
Metabolic reprogramming in diabetes and cancer: the role of PI3K/AKT/mTOR and beyond.
American journal of cancer research·2026